The CoDDaC records details of authorities from the New South Wales (NSW) Ministry of Health to prescribe or supply a Schedule 8 drug, including methadone and buprenorphine under the NSW Opioid Treatment Program (OTP; subcollection 1), Schedule 8 opioids for the ongoing management of chronic pain (subcollection 2), and psychostimulants for the treatment of Attention Deficient Hyperactivity Disorder in children and adults (subcollection 3). The CoDDaC includes data relating to patients and prescribers in the Australian state of New South Wales. All participant numbers are as of 30 June 2021.
Study design
Registry
Number of participants at first data collection
68,926 (participants - subcollection 1)
146,860 (participants - subcollection 2)
133,794 (participants - subcollection 3)
Recruitment is ongoing
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
1985 (retrospective data)
2016 (CoDDaC inception)
Primary Institutions
New South Wales Ministry Of Health
Profile paper DOI
Not available
Funders
New South Wales Ministry of Health
Ongoing?
Yes
Data types collected

Engagement
Keywords